| Tag | Content |
|---|
EnhancerAtlas ID | HS139-30367 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr2:152171260-152173290 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFE2L1 | MA0089.2 | chr2:152172268-152172283 | GCATGACACAGCAGA | + | 6.04 | | Nfe2l2 | MA0150.2 | chr2:152172266-152172281 | CGGCATGACACAGCA | + | 6.51 | | Nr2f6(var.2) | MA0728.1 | chr2:152173187-152173202 | GAGGTCAGGAGTTCA | + | 6.22 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_68327 | chr2:152171471-152196946 | TC32 | | SE_68328 | chr2:152171471-152196946 | TC32 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 152172000 | 152172475 | | chr2 | 152171750 | 152171851 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I151315 | chr2 | 152171673 | 152172824 |
|
Enhancer Sequence | CACTTTACCA CTATTTTGTT TTATTTTTCT TATTAATATA AGAAGACAGG AATGTCAGGC 60
CTCTGAGCCC AAGCTAAGCC ATCATATCCC CAGTAACCTG CATATATACA TCCAGATGTC 120
CTGAAGCAAC TGAAGTTCCA CAGAAGTGAA AATAGCTTAA CTGATGACAT TCCACCATTG 180
TGATTTGTTT CTGCCCCACC CTAACTGATC AATGTTCTTT ATAATCTCCC CCACTCTTAA 240
GAAATTTCTT TGTAATTCTC CCCACCCTTG AGAATGTACT TTGTGAGATC CACCCCCTGC 300
TCCCAAAACA TTGCTCTTAA CTCCACCGCC TATCCCAAAA CCTATAAGAA CTAATGATAA 360
TCCCACCACC CTTGCTGACT CTCCTTCGGA CTCAGCCCAC CTGCACCCCG GTGAAATAAA 420
CAGCCTTGTT GCTCACACAA AGCCTGTTTG GTGGTCTCTT CACACAGACT TGCGTGAGAC 480
AACCCTCACA GGGGAACCTG AAGGTCTAGA TCACAGGAGG AGATTCTGAC ATTAACTGCA 540
GCTGAGTCAA TTTAGAGAGC TGAGTGAAAT ACAGGGGTAG AGGAAGCAGC GGGATAAGCC 600
CTGTGGGCTC TCTGGGTCTC CGGGGAAGCC ATTTCTGCCT TGCCTCACAG GAGTCCTTGG 660
GGAGGGCTGC CAGAGGAACT GGGAAAAGAC CACAGGGAAA AGGAAACCTC CAGCTGAACT 720
GTGTAACAAT TCCAACAGAA TGCAAAATCT CCTGGCCAGA ACTCCGGGGA GGGAGTGATT 780
CTGGTGTGCA GACTCCAAAA GCAGGCAGAC ACGAAAGCCC TGCTTGCTTT TGCAGCTGGG 840
AGACTGGTAG CCTGCAGCAA GTTCTCAGCC CTGCTCGCCC ACTGCTGGAA ACAGACTTGG 900
TGCTGTTGGG AGTCGGGGGA AAGGTGGGAG TGAGACCAGC CTTTTGGGTT GCATGGGAGC 960
TGGGTGAGGC CTGTGACTGC CAGCTTTCTC CCACTTCCCT GACAACCGGC ATGACACAGC 1020
AGAGGCAGAC ATAATCCTCC TGGGAACATT ACTCCATTGA CTTGGGAACC ACACTCCCAT 1080
CCCCCAAAGC AGCCGCAGCC AAGACCTGCC CAAAGACAGT CTGAACTCAG ACACTTCTAG 1140
CCCTTCCCCG ACCTGATGGT CCTTCCCTAT GTACCCTGCT AGCTGAAGAC AAAGGGCATA 1200
TACTCTTGGG AGTTCTAGGC CCCTACCCAC CACCTGATCC TCCCTATAAT ACCACAGCTG 1260
ATGCTCTCTT GAAAGCACCA CCTCCCGGCA GGAGACCAAC CAACACAAAA ATAGAGCATT 1320
AAACAACCAA AAATAAGGAC CCTCACAGAG TCCATTTCAC TCCCCTGCCA CCTCCACCAG 1380
AACAGGTGCT GGTATCCACG GCTGAGAGAC CCACAGACGG TTCACATCAC AGGACTCTGT 1440
GCAGACAACC CCCAGTACCA GCCCAGAGCC TGGCAGACCT GCTGAAGAGC TAGATCCAGA 1500
AGAGAGATAA TAATCATTAC AGCTCAGCTT TCAGGAAGCC ATATCCATAG GAAAAGGGCA 1560
AGTACTACAT TAAGGGAACA CCCCATGGGA CAAAAGAATC TGAACAGCAG CTTTGAGCCC 1620
TAGACCTTTC CTCTGACATA GACTATCCAA ATGAGAAGGA ACCAGAAAAA CAATTCTGGT 1680
AATATGACAA AGCAAGGCTC TTTAACAGCC CCAAAAAATG ACACTAGCTC ACCAGCAATG 1740
AATCCAAACC AAGAAGAAAT CTATGATTTG CCTAAAAAAG AATTCAGAAA ATCAGTCATT 1800
AAACTAATCA AGGAGGCACC AGAGAAAGAT GAAGTCCAAG TTAAGGGAAT TTAAAAAATG 1860
AGGCCAGGTG CGGTGGCTCA CACTTGTAAT CCCAGCAATT TGGGAAGCCA AGGCGGTCGG 1920
ATCACCTGAG GTCAGGAGTT CAAGACCAGC CTGGCCAACA TGGTGGTGAA ACCCCGTCTC 1980
TACTAAAAAT ACAAAAATTA GCCCAGCGCT GTGACAGGCA CCTATAATCC 2030
|
